Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026
Achieve Life Sciences, a specialty pharmaceutical company focused on cytisinicline for nicotine dependence treatment, announced it will release its Q1 2026 financial results and hold a conference call on May 12, 2026. The announcement comes as the FDA is reviewing its New Drug Application with a PDUFA date set for June 20, 2026, potentially approvi…